Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Marrow Neoplasms × Stem Cell Transplantation × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 56 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Myelodysplastic Syndromes 40 Multiple Myeloma 34 Lymphoma 32 Leukemia 29 Lymphoma, Non-Hodgkin 26 Leukemia, Lymphocytic, Chronic, B-Cell 21 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Hodgkin Disease 18 Hematologic Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 12 Primary Myelofibrosis 11 Leukemia, Myelomonocytic, Chronic 11 Neuroblastoma 10 Neoplasms, Plasma Cell 9 Leukemia, Biphenotypic, Acute 9 Graft vs Host Disease 9 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Leukemia, Myelomonocytic, Juvenile 7 Burkitt Lymphoma 7 Breast Neoplasms 6 Rhabdoid Tumor 5 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 5 Lymphoma, Mantle-Cell 5 Wilms Tumor 4 Polycythemia Vera 4

Interventions

Lenalidomide 2 Dexamethasone 2 Bortezomib 2 ruxolitinib 1 darinaparsin 1 carfilzomib 1 belinostat 1 Stem Cell Transplantation 1 SCIO-469 1 Low-Level Light Therapy 1 Hydroxyurea 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting

Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡